U.S. FDA has granted accelerated approval of Loargys® (pegzilarginase-nbln) for the treatment of hyperargininemia in patients 2 years and older with Arginase 1 Deficiency (ARG1-D)
LOARGYS is the first and only therapy proven to lower arginine in patients 2 years of age and older living…
